HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

UB 8902

an antibacterial agent

Also Known As:

UB-8902; UB8902

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Quinolones: 2938
        Fluoroquinolones: 5348
        Ciprofloxacin: 6260
        UB 8902: 1

Experts

1.	Docobo-Pérez, F: 1 article (10/2011)
2.	Domínguez-Herrera, J: 1 article (10/2011)
3.	López-Rojas, R: 1 article (10/2011)
4.	Pachón, J: 1 article (10/2011)
5.	Sánchez-Céspedes, J: 1 article (10/2011)
6.	Vila, J: 1 article (10/2011)

Related Diseases

1.	Sepsis (Septicemia) 10/01/2011 - "In the in vivo experiments in mice, the toxicity of UB-8902, its 50% protective dose (PD(50)) (peritoneal sepsis model), its pharmacokinetic/pharmacodynamic (PK/PD) parameters and its efficacy in a pneumonia model were studied. "
2.	Pneumonia (Pneumonitis) 10/01/2011 - "In the pneumonia model, UB-8902 decreased the bacterial lung concentration [4.62 colony-forming units (CFU)/g and 4.15log(10)CFU/g] and positive blood cultures (60% and 62.5%) for Ab58 and Ab33, respectively, compared with the control. " 10/01/2011 - "In the in vivo experiments in mice, the toxicity of UB-8902, its 50% protective dose (PD(50)) (peritoneal sepsis model), its pharmacokinetic/pharmacodynamic (PK/PD) parameters and its efficacy in a pneumonia model were studied. "